Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
2020 · Alimentary Pharmacology & Therapeutics · 85 citations
https://doi.org/10.1111/apt.15689
A
Alexander Bodelier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
1.7K
Citations
22
h-index
29
i10-index
Alexander Bodelier is an academic researcher from Amphia Ziekenhuis. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 22, co-authored 80 publications.
ORCID: 0000-0002-2329-9995Papers by this author
worksHigh Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score
2016 · Digestive Diseases and Sciences · 34 citations
https://doi.org/10.1007/s10620-016-4397-6
Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study
2019 · Clinical Pharmacology & Therapeutics · 33 citations
https://doi.org/10.1002/cpt.1712
Long-Term Outcomes of Early Surgery vs Endoscopy First in Chronic Pancreatitis
2024 · JAMA Surgery · 21 citations
https://doi.org/10.1001/jamasurg.2024.5182
Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study
2024 · Inflammatory Bowel Diseases · 3 citations
https://doi.org/10.1093/ibd/izae095
The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease
2025 · Alimentary Pharmacology & Therapeutics · 3 citations
https://doi.org/10.1111/apt.18496
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat